Clinical investigation of medicinal products for the treatment of multiple sclerosis

  • Email
  • Help
Current effective version

Revision 2 - Adopted guideline

Reference numberCHMP/771815/2011 Rev. 2
Published31/03/2015
Effective from01/10/2015
KeywordsMultiple sclerosis, neurological disease
DescriptionThis document provides guidance on the evaluation of medicinal products for the treatment of multiple sclerosis. It primarily focuses on treatments aimed to modify disease progression. In addition it concerns the treatment of relapses, repair and restoration of functioning and symptomatic improvement.


Document history

Revision 2

Current version

Adopted guideline


Draft guideline


Concept paper

In operation: 01/10/2015–present


Published: 09/10/2012


Published: 08/07/2011

Revision 1

Adopted guideline


Overview of comments


Draft guideline

In operation: 01/06/2007–30/09/2015


Published: 16/11/2006


Published: 15/09/2005


Related content


How helpful is this page?

Average rating:

 Based on 1 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
1 ratings
    

Tell us more